ONC201 Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Antagonist of dopamine receptor D2 (DRD2) and caseinolytic protease proteolytic subunit (ClpP), TIC10

Filter by location:

Other1 trial

Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

Phase 3

Birmingham, Alabama1 trial

Combination Therapy for the Treatment of Diffuse Midline Gliomas

University of Alabama at Birmingham

Phase 2

Chapel Hill, North Carolina1 trial

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Lineberger Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.